Locally advanced Gastric Cancer; Role of chemoradiation Dr. - - PowerPoint PPT Presentation

locally advanced
SMART_READER_LITE
LIVE PREVIEW

Locally advanced Gastric Cancer; Role of chemoradiation Dr. - - PowerPoint PPT Presentation

Locally advanced Gastric Cancer; Role of chemoradiation Dr. Solomon Kibudde Registrar, Clinical and Radiation Oncology Dr. Waleed Begg, Consultant, GI Tumours Stellenbosch University/ Tygerberg Hospital Disclosure None to declare Mr. M 54


slide-1
SLIDE 1

Locally advanced Gastric Cancer; Role of chemoradiation

  • Dr. Solomon Kibudde

Registrar, Clinical and Radiation Oncology

  • Dr. Waleed Begg, Consultant, GI Tumours

Stellenbosch University/ Tygerberg Hospital

slide-2
SLIDE 2

Disclosure

None to declare

slide-3
SLIDE 3
  • Mr. M

54 yr male, HIV+ on ARVs

Presented vomiting for 2 weeks

  • Epigastric pain,
  • Early satiety
  • LOW 20 kg/5 mo

History

  • Occupation - Painter, Farm worker , builder
  • Social - Married, 4 children; smoking 20 pack years
  • FH (-)
slide-4
SLIDE 4

Physical Exam

  • PS 1
  • Left axilla LN+ node (reactive)
  • W 47.4Kg
  • Epigastric tenderness
  • Other systems NAD

Laboratory workup

Hb CD4 HIVVL CEA Alb ALT AST GGT Ur Cr

16.8 529 LDL 2.8 32 19 23 17 2.5 81

slide-5
SLIDE 5

Diagnostic workup

  • Gastroscopy lesion antral part of the stomach
  • Gastric biopsy Invasive Gr3 ACa
  • Signet ring cell morphology
  • Antral wall and pylorus thickening
  • LN(-) or ascites
  • No liver or lung metastases
slide-6
SLIDE 6

Management

slide-7
SLIDE 7

Surgical resection

  • Subtotal gastrectomy
  • D2 lymphadenectomy
  • Roux-en-Y anastomosis

Pathology

Tumour invading subserosa, Aca, signet ring, grade 3

  • Vascular invasion

+

  • Lymphatic invasion

+

  • Perineural invasion

+

  • ENE

+

  • Margins

15 mm, distal

  • Lymph nodes

17/ 19 +

slide-8
SLIDE 8

MDT

Gastric antrum ACa pT3pN3bM0 – stage IIIB

  • Co-morbidities:
  • HIV+ (CD4 595, HIVVL - LDL),
  • PS 1
Rad Onc S/W Surgeons Dietician Radiologist

Recommendations

  • Adjuvant CRT

5-FU Weeks 1 & 5 45Gy/25#s Mon-Fri 5FU/LV X4 post CRT

slide-9
SLIDE 9

Radiotherapy planning

  • CT simulation
  • CTV = gastric bed
  • incl. residual stomach,

anastomoses, draining LN

  • PTV = CTV + 1cm
  • OAR
  • Lungs V20≤25%
  • Spinal cord Max ≤45Gy
  • Heart V40<30%
  • Left Kidney V20≤33%, R kidney V20<66%
  • Small bowel V45<150cc
  • Liver V30<60%, MLD <32Gy
slide-10
SLIDE 10

3DCRT Field arrangement

slide-11
SLIDE 11

Dose Volume Histogram

Lt Kidney Liver Rt Kidney Heart Lt Lung Rt Lung PTV

slide-12
SLIDE 12

Gastric CRT Current progress

Wk 1 Radiotherapy 25fractions @1.8Gy Mon-Fri = 45Gy Wk 5 Wk 4 Wk 3 Wk 2 5-FU 1g/m2 D1-4 5-FU 1g/m2 D1-4

  • Toxicities:
  • Vomiting Gr2
  • Dyspepsia
  • Anorexia, Fatigue
  • Dumping syndrome
  • Dietary support
  • Nutritional counseling
  • VitB12 and FeSO4
  • Psychosocial support
  • Treatment of acute toxicities
slide-13
SLIDE 13

Discussion point

Treatment options for LAG cancer include surgery

  • Perioperative chemotherapy
  • Neoadjuvant chemotherapy
  • Neoadjuvant chemoradiation
  • Adjuvant chemotherapy
  • Adjuvant chemoradiation

How would you have treated this patient?

slide-14
SLIDE 14

Thank you

Acknowledgements

  • Mr M
  • Dr. W. Begg/ Dr. P. Barnardt
  • Prof. H M Simonds